118 related articles for article (PubMed ID: 7509391)
1. Gallium arsenide-induced increase in serum corticosterone is not responsible for suppression of the IgM antibody response.
Burns LA; Spriggs TL; Fuchs BA; Munson AE
J Pharmacol Exp Ther; 1994 Feb; 268(2):740-6. PubMed ID: 7509391
[TBL] [Abstract][Full Text] [Related]
2. Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response.
Sikorski EE; Burns LA; Stern ML; Luster MI; Munson AE
Toxicol Appl Pharmacol; 1991 Aug; 110(1):129-42. PubMed ID: 1871769
[TBL] [Abstract][Full Text] [Related]
3. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. I. Pharmacokinetics after in vitro and in vivo exposure.
Burns LA; Munson AE
J Pharmacol Exp Ther; 1993 Apr; 265(1):144-9. PubMed ID: 8386233
[TBL] [Abstract][Full Text] [Related]
4. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. II. Nature and identification of reversing factors.
Burns LA; Munson AE
J Pharmacol Exp Ther; 1993 Apr; 265(1):150-8. PubMed ID: 8474002
[TBL] [Abstract][Full Text] [Related]
5. Evidence for arsenic as the immunosuppressive component of gallium arsenide.
Burns LA; Sikorski EE; Saady JJ; Munson AE
Toxicol Appl Pharmacol; 1991 Aug; 110(1):157-69. PubMed ID: 1651571
[TBL] [Abstract][Full Text] [Related]
6. Suppression of splenic accessory cell function in mice exposed to gallium arsenide.
Sikorski EE; Burns LA; McCoy KL; Stern M; Munson AE
Toxicol Appl Pharmacol; 1991 Aug; 110(1):143-56. PubMed ID: 1714636
[TBL] [Abstract][Full Text] [Related]
7. Reversal of gallium arsenide-induced suppression of the antibody response by a mixed disulfide metabolite of meso-2,3-dimercaptosuccinic acid.
Burns LA; Butterworth LF; Munson AE
J Pharmacol Exp Ther; 1993 Feb; 264(2):695-700. PubMed ID: 8382280
[TBL] [Abstract][Full Text] [Related]
8. Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation.
Lewis TA; Munson AE; McCoy KL
J Pharmacol Exp Ther; 1996 Sep; 278(3):1244-51. PubMed ID: 8819508
[TBL] [Abstract][Full Text] [Related]
9. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice.
Sikorski EE; McCay JA; White KL; Bradley SG; Munson AE
Fundam Appl Toxicol; 1989 Nov; 13(4):843-58. PubMed ID: 2695379
[TBL] [Abstract][Full Text] [Related]
10. Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55).
Burns LA; Munson AE
J Pharmacol Exp Ther; 1993 Apr; 265(1):178-86. PubMed ID: 8097242
[TBL] [Abstract][Full Text] [Related]
11. Direct exposure to gallium arsenide upregulates costimulatory activity of murine macrophages.
Caffrey-Nolan RE; McCoy KL
Toxicol Appl Pharmacol; 1998 Aug; 151(2):330-9. PubMed ID: 9707509
[TBL] [Abstract][Full Text] [Related]
12. Gallium arsenide augments antigen processing by peritoneal macrophages for CD4+ helper T cell stimulation.
Hartmann CB; McCoy KL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):365-72. PubMed ID: 8975760
[TBL] [Abstract][Full Text] [Related]
13. Arsenic in the sera of gallium arsenide-exposed mice inhibits bacterial growth and increases host resistance.
Burns LA; McCay JA; Brown R; Munson AE
J Pharmacol Exp Ther; 1993 May; 265(2):795-800. PubMed ID: 8496824
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate.
Loveless SE; Hoban D; Sykes G; Frame SR; Everds NE
Toxicol Sci; 2008 Sep; 105(1):86-96. PubMed ID: 18559402
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Gallium Arsenide (CAS No. 1303-00-0) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Sep; 492():1-306. PubMed ID: 12563348
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the primary humoral immune response following exposure of male rats to 17beta-estradiol or flutamide for 15 days.
Ladics GS; Smith C; Nicastro SC; Loveless SE; Cook JC; O'Connor JC
Toxicol Sci; 1998 Nov; 46(1):75-82. PubMed ID: 9928670
[TBL] [Abstract][Full Text] [Related]
17. Gallium arsenide selectively up-regulates inflammatory cytokine expression at exposure site.
Becker SM; McCoy KL
J Pharmacol Exp Ther; 2003 Dec; 307(3):1045-53. PubMed ID: 14560044
[TBL] [Abstract][Full Text] [Related]
18. Gallium arsenide modulates proteolytic cathepsin activities and antigen processing by macrophages.
Lewis TA; Hartmann CB; McCoy KL
J Immunol; 1998 Sep; 161(5):2151-7. PubMed ID: 9725206
[TBL] [Abstract][Full Text] [Related]
19. Thymic atrophy caused by ethanol in a mouse model for binge drinking: involvement of endogenous glucocorticoids.
Han YC; Lin TL; Pruett SB
Toxicol Appl Pharmacol; 1993 Nov; 123(1):16-25. PubMed ID: 8236255
[TBL] [Abstract][Full Text] [Related]
20. Immunotoxicological characteristics of sodium methyldithiocarbamate.
Pruett SB; Barnes DB; Han YC; Munson AE
Fundam Appl Toxicol; 1992 Jan; 18(1):40-7. PubMed ID: 1601208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
